Opening Recap
Market Pulse: Markets ripped higher yesterday as energy and chip stocks led the charge after investors shrugged off pip-squeak headlines. A broad rally took hold, lifting major indexes in a show of unapologetic optimism.
Key Movers: Energy names and semiconductors drove most gains, while 5G plays and robotics names lagged on insider sell-offs, punctuating a clear sector split.
Macro & Politics: The White House just widened its tariff net beyond the Supreme Court’s remit, stoking fresh supply-chain fears that could crimp margins if Washington keeps bouncing between trade gambits.
What’s Next: Today, traders zero in on the Fed’s pipeline for clues on the next rate call—if the market’s mood holds steady, all bets are on a twist-less continuation.
Market Commentary
What everyone’s missing is that the tariff push from President Trump (reports in The Times of India detail his Section 232 expansion) is not just a trade skirmish—it’s a direct tax on manufacturers battling slim margins. While Wall Street Zen’s Hold upgrade on Editas Medicine (ETF Daily News) grabbed headlines, no one’s calling out that biotech supply chains need the same scrutiny as steel and pharma imports. If you’re not weaving policy hedges into your biotech thesis, you’re begging for a nasty wake-up call.
Consider the odd couple of CRISPR and AI drug-discovery platforms: Editas Medicine’s upgrade signals mid-term runway, but “Invest In AI—But Pick Your Poison” (Forbes) warns that consumer-grade models are hype traps. The real jackpot is industrial biotech tooling, where precision matters more than clicks. Link those insights and you get a thesis that bets on platforms rebuilding pharma R&D, not flashy consumer apps. That’s how you separate market noise from genuine alpha.
Here’s your playbook: focus on themes with real ROI—gene-editing names with firm delivery roadmaps (see ETF Daily News’ upgrade on EDIT), AI drug-discovery platforms, solid-state battery teasers, and industrial robotics where insiders still see value despite last week’s sell-off. Hedge tariff risks with foreign sourcing or cost-pass-through strategies. Hold conviction on core themes and let the circus in Washington provide opportunity, not panic.
📈 Breaking Financial News
Editas Medicine (NASDAQ:EDIT) Upgraded to Hold at Wall Street Zen
Wall Street Zen upgraded shares of Editas Medicine (NASDAQ:EDIT – Free Report) from a sell rating to a hold rating in a report published on Friday. A number of other equities research analysts also recently commented on EDIT. HC Wainwright reaffirmed a “buy” …
Analysts Set Ceva, Inc. (NASDAQ:CEVA) Price Target at $35.60
Shares of Ceva, Inc. (NASDAQ:CEVA – Get Free Report) have been assigned an average rating of “Buy” from the five analysts that are covering the stock, MarketBeat reports. Five equities research analysts have rated the stock with a buy rating. The average 1 ye…
Serve Robotics (NASDAQ:SERV) Trading Down 6.5% on Insider Selling
Serve Robotics Inc. (NASDAQ:SERV – Get Free Report)’s share price was down 6.5% during trading on Thursday following insider selling activity. The company traded as low as $11.61 and last traded at $12.00. Approximately 11,555,663 shares were traded during mi…
Richtech Robotics (NASDAQ:RR) Shares Gap Down Following Insider Selling
Richtech Robotics Inc. (NASDAQ:RR – Get Free Report)’s stock price gapped down prior to trading on Thursday following insider selling activity. The stock had previously closed at $4.41, but opened at $4.14. Richtech Robotics shares last traded at $4.19, with …
Humanoid robots still 10 years away from homes, says Agility Robotics co-founder
Despite market anticipation for the deployment of humanoid robots in home applications, significant safety risks still remain. Because of this, Jonathan Hurst, co-founder of US-based humanoid robot startup Agility Robotics, estimates that it will take at leas…
ELON MUSK IS ABOUT TO MAKE TESLA SKEPTICS LOOK LIKE COMPLETE IDIOTS… AGAIN
Remember when “experts” said Tesla would never work? That electric cars were a joke? That Elon was just a “crazy dreamer”? Those same morons are now saying robotaxis are “decades away.” WRONG. Tesla's robotaxi fleet launches THIS YEAR. The $34 trillion revolution starts NOW. Marc Lichtenfeld reveals his thoughts on which companies will ride Elon's coattails to massive profits. Don't be the fool who bets against Musk AGAIN.
🔍 Market Analysis & Insights
Head to Head Comparison: HeartCore Enterprises (NASDAQ:HTCR) versus Net Medical Xpress Solutions (OTCMKTS:NMXS)
HeartCore Enterprises (NASDAQ:HTCR – Get Free Report) and Net Medical Xpress Solutions (OTCMKTS:NMXS – Get Free Report) are both computer and technology companies, but which is the superior investment? We will contrast the two businesses based on the strength…
Invest In AI But Be Careful Which Type Catches Your Eye
Types of artificial intelligence have been around for decades. They’ve proven themselves. Generative AI, though, is raising some alarms for investors.
5G Stocks To Add to Your Watchlist – September 24th
EchoStar, KT, Ceva, Radcom, Mobix Labs, Datasea, and Franklin Wireless are the seven 5G stocks to watch today, according to MarketBeat’s stock screener tool. 5G stocks are shares of companies directly involved in the development, deployment and commercializat…
Wall Street Zen Downgrades Alphatec (NASDAQ:ATEC) to Hold
Wall Street Zen cut shares of Alphatec (NASDAQ:ATEC – Free Report) from a buy rating to a hold rating in a research report sent to investors on Friday morning. Several other research firms have also recently commented on ATEC. Lake Street Capital upgraded sha…
Teradyne (NASDAQ:TER) vs. Exro Technologies (OTCMKTS:EXROF) Financial Analysis
Teradyne (NASDAQ:TER – Get Free Report) and Exro Technologies (OTCMKTS:EXROF – Get Free Report) are both computer and technology companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional own…
Terrifying reason Trump killed the U.S. penny?
You see, the U.S. is facing a looming shortage that could cripple the economy with runaway inflation… and send one tiny clutch of investments soaring in the weeks ahead. Former White House Advisor, Jim Rickards, just came forward to share this startling story.
💰 Investment Opportunities
Artificial Intelligence Stocks To Follow Today – September 25th
SoundHound AI, BigBear.ai, Tempus AI, Evaxion A/S, and Upstart are the five Artificial Intelligence stocks to watch today, according to MarketBeat’s stock screener tool. Artificial intelligence stocks are shares of publicly traded companies that develop, prod…
Trump expands tariffs beyond US Supreme Court's reach
President Trump is rapidly expanding Section 232 tariffs on diverse imports, including pharmaceuticals and machinery, as a backup against potential Supreme Court rulings on his earlier tariffs. These national security-based levies, covering over a third of U.…
Why Today's Humanoids Won't Learn Dexterity
Article URL: https://rodneybrooks.com/why-todays-humanoids-wont-learn-dexterity/
Comments URL: https://news.ycombinator.com/item?id=45392922
Points: 6
# Comments: 0
As Trump expands tariff net, why questions loom over the effectiveness of a trade deal with the US
Trump’s move assumes significance as India is in the middle of negotiations with the US, and the elimination of reciprocal tariffs is a key ask from the Indian side, though sectoral tariffs are not part of the talks.
ECARX Collaborates with Monolithic Power Systems (MPWR) for Automotive AI Integration
Monolithic Power Systems, Inc. (NASDAQ:MPWR) is one of the best dividend stocks to buy. On July 22, ECARX Holdings Inc. (NASDAQ:ECX) reported a new strategic…
NEVER BET AGAINST ELON MUSK (Unless You Enjoy Being WRONG)
PayPal skeptics: WRONG. Tesla doubters: WRONG. SpaceX critics: WRONG. Starlink naysayers: WRONG. Now the same “experts” say robotaxis won't work. THEY'RE WRONG AGAIN. Elon Musk is about to trigger a $34 trillion market explosion. Marc Lichtenfeld reveals how to profit from Musk's next masterstroke. Stop betting against genius. Start profiting from it.